Diabetes, Neuro And Pain Franchises Propel Medtronic To A Strong Finish

Medtech's number one player Medtronic reported solid fourth-quarter results, beating market analysts' forecasts and wrapping up a strong fiscal year 2018. Star performers in the final quarter were its diabetes and restorative therapies businesses.